PharmaShots Weekly Snapshot (February 04-08, 2019)
Published: 7 Feb,2019 | Tags: Galapago, Signs, Worldwide, Development,Commercialization, Agreement, Evotec,Fibrotic Diseases
Published: 7 Feb,2019 | Tags: Orthofix Medical, M6-C, Artificial Cervical Disc, Receives, FDA, Approval, Cervical Disc Degeneration
3. Genagon Signs a Worldwide License Agreement with Ligand for its Omniab Technology
Published: 8 Feb,2019 | Tags: Genogon, Signs, Worlwide, License, Agreement, Ligand, Omniab, Technology
Published: 8 Feb,2019 | Tags: BioMarin, Reports, Results, Brineura, cerliponase alfa, Study, CLN2 Disease, Children, 3yrs.
Published: 8 Feb,2019 | Tags: Medtronic, Pipeline Flex Embolization, Device, Receives, FDA, Expanded, Indication, Approval, Intracranial Aneurysms, IAs
6. P&G to Acquire 'This is L.' for its Feminine Care Products in the US
Published: 7 Feb,2019 | Tags: P&G, Acquire, This is L. , Feminine Care, Product, the US
7. AstraZenecas Fasenra Receives Orphan Drug Designation (ODD) For Hypereosinophilic Syndrome (HES)
Published: 7 Feb,2019 | Tags: AstraZeneca, Fasenra, Receives, Orphan Drug Designation,ODD,Hypereosinophilic Syndrome, HES
Published: 7 Feb,2019 | Tags: Recordati, Licenses, Exclusive, Commercilization, Rights, Juxtapid, lomitapide, Aegerion Pharmaceuticals
Published: 7 Feb,2019 | Tags: Paratek, Reports, Results, Nuzyra, Omadacycline, P-III, OPTIC, OASIS-1, Studies, Pneumonia, Skin Infections, Adults, Published, NEJ
Published: 6 Feb,2019 | Tags: Sanofi, Cablivi, caplacizumab-yhdp, Receives, FDA, Approval, Acquired Thrombotic Thrombocytopenic Purpura, aTTP, Adults
11. GSK Signs a Worldwide Development & Commercialization Collaboration with Merck KGaA, for $4.2B
Published: 5 Feb,2019 | Tags: GSK, Signs, Worldwide, Development, Commercialization, Collaboration, Merck KGaA, $4.2B
Published: 6 Feb,2019 | Tags: Sanofi, Report, Results, Isatuximab, P-III, ICARIA-MM study, Relapsed/Refractory, Multiple Myeloma, MM
Published: 6 Feb,2019 | Tags: Merck, Reports, Acceptance, NDA, FDA, Imipenem/Cilastatin, Relebactam, Complicated, Urinary Tract, Intra-Abdominal, Infections, Adults
14. Kyowa Kirin Signs an Exclusive Commercialization Agreement with Hisamitsu for its HP-3000
Published: 6 Feb,2019 | Tags: Kyowa Kirin, Signs, Exclusive, Commercialization, Agreement, Hisamitsu, HP-300
Published: 6 Feb,2019 |Tags: Genentech, Signs, Development, Commercialization, Agreement, Xencor, IL-15, XmAb24306 Programs
Published: 6 Feb,2019 |Tags: AstraZeneca, MEDI8897, Receives, FDA, Breakthrough Therapy Designation, BTD, EMA, PRIME Designation, Lower Respiratory Tract Infection, LRTI, Infants
17. Eisai and Purdue Report Result of Lemborexant in P-III SUNRISE 2 Study for Insomnia in Adults
Published: 6 Feb,2019 |Tags: Eisai, Purdue, Report, Result, Lemborexant, P-III, SUNRISE 2 Study, Insomnia, Adults
18. BioLineRX's BL-8040 Receives FDA's Orphan Drug Designation (ODD) for Pancreatic Cancer
Published: 4 Feb,2019 |Tags: BioLineRX, BL-8040, Receives, FDA, Orphan Drug Designation, ODD, Pancreatic Cancer
Published: 4 Feb,2019 |Tags: Eli Lilly, Reports, Results, Olumiant, baricitinib, P-III, BREEZE-AD1, BREEZE-AD2, study, Moderate, Severe Atopic Dermatitis, AD
20. Argenx Signs a Worldwide License Agreement with Halozyme for its ENHANZE Technology
Published: 5 Feb,2019 |Tags: Argenx, Signs, Worldwide, License, Agreement, Halozyme, ENHANZE Technology
Published: 4 Feb,2019 |Tags: Merck, Keytruda, pembrolizumab, Receives, CHMP, Recommendation, 1L, Metastatic, Squamous, Non-Small Cell Lung Cancer,NSCLC
22. Novartis' Kymriah Receives NICE Approval for R/R Diffuse Large B-cell lymphoma (DLBCL) in Adults
Published: 4 Feb,2019 |Tags: Novartis, Kymriah, Receives, NICE, Approval, R/R, Diffuse Large B-cell Lymphoma, DLBCL, Adults
Published: 4 Feb,2019 |Tags: Evolus, Jeuveau, prabotulinumtoxinA-xvfs, Receives, FDA Approval, Moderate-to-Severe, Glabellar Lines, Adults
24. Roche Recalls Lots of Coaguchek Xs Pt Test Strips with FDA's Class I Warning
Published: 4 Feb,2019 |Tags: Roche, Recalls, Lots, Coaguchek Xs Pt Test Strips, FDA, Class I, Warning